Faron Pharmaceuticals Oy ( (GB:FARN) ) has issued an announcement.
Faron Pharmaceuticals Oy has announced a change in its voting rights structure due to a private placement. The Fourth Swedish National Pension Fund’s holding in Faron Pharmaceuticals has fallen below the 3% threshold, indicating a shift in shareholder composition which may impact the company’s governance and stakeholder influence.
More about Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy is a biopharmaceutical company that operates in the healthcare industry. The company is focused on developing novel treatments for medical conditions, particularly within the field of immunology and cancer therapy.
YTD Price Performance: -19.76%
Average Trading Volume: 23,486
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £193.7M
See more insights into FARN stock on TipRanks’ Stock Analysis page.